Sabrina is a group scientist in the Department of Experimental Oncology at IEO (European Institute of Oncology in Milan, Italy). Here, she is leading a project about gut microbiome in healthy aging and she is interested in understanding the role of gut microbiome in: modulating cancer risk, preventing cancer development and responding to cancer treatment especially for immunotherapy approaches.
She obtained her PhD in Microbiology in the International Doctoral Program in Biomolecular Sciences at CIBIO, University of Trento (Italy) and she performed her postdoctoral training in the Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai (New York, USA) where she developed a viability assay to study:
- The viable gut microbiome during fecal microbial transplantation in Clostridium difficile patients.
- The nasal microbiome and its relation to exposure to secondhand tobacco smoke.
- The re-shaping of gut microbiome in infants delivered by C-section.
For her work she received the Robin Chemers Neustein Postdoctoral Fellowship Award, the prestigious for talented early-career female scientists in recognition for her talent and innovation in the biomedical sciences.
Most Relevant Publications
Infant gut microbiome is enriched with Bifidobacterium longum ssp. infantis in Old Order Mennonites with traditional farming lifestyle.
Insights into the genome structure of four acetogenic bacteria with specific reference to the Wood-Ljungdahl pathway.
Nat Med, 2016
Microbiota-driven transcriptional changes in prefrontal cortex override genetic differences in social behavior.